Drug intelligence / Profile preview

diosmin + hesperidin + troxerutin

Development stage
Unknown
Lead developer
Omikron
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Diosmin + hesperidin + troxerutin is a fixed-dose combination of three plant-derived bioflavonoids developed by Omikron Italia. The combination acts synergistically as a phlebotonic and vasoprotectant to improve venous tone, enhance microcirculation, and reduce capillary permeability. Diosmin increases venous tone by inhibiting catechol O-methyltransferase (COMT), thereby prolonging the vasoconstrictive effect of norepinephrine on the venous wall. Hesperidin and troxerutin contribute to vascular integrity by inhibiting enzymes like hyaluronidase, elastase, and collagenase, which degrade the extracellular matrix and compromise capillary walls. This combination is marketed as a dietary supplement (under the brand name Triade) and is used to manage symptoms of chronic venous disease (CVI), pelvic congestion syndrome, and acute hemorrhoidal disease.

Brand names
TriadeTriade 800Triade800Triade-800Triade CremaGelTriade HTroxiven RetardVenolix
Other names
diosmin, hesperidin, and troxerutinflavonoid mixture of diosmin, hesperidin, and troxerutinflavonoids mixture (diosmin, troxerutin, hesperidin)
02

Targets

COMT (Catechol-O-methyltransferase)MMP12 (Macrophage Metalloelastase)ElastaseHYAL (Hyaluronidase family (HYAL))

Beyond the preview

Go deeper on diosmin + hesperidin + troxerutin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diosmin + hesperidin + troxerutin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call